Targeting the Synthetic Vulnerability of <i>PTEN</i> -Deficient Glioblastoma Cells with MCL1 InhibitorsChao Chen, Fan Lin, Xia Zhang et al.|Molecular Cancer Therapeutics|2020Cited by 20